With whale wallets picking up TARS AI (TAI) amid a new all-time high creation, will the bull run cross the $0.50 milestone?
Hosted on MSN8d
Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a BetTarsus Pharmaceuticals, Inc. (TARS) closed the last trading session at $50.40, gaining 10.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...
Hosted on MSN1mon
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?The market expects Tarsus Pharmaceuticals, Inc. (TARS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.90. This compares to loss of $1.28 per share a year ago.
The market expects Tarsus Pharmaceuticals, Inc. (TARS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback